Elanco Animal Health Incorporated
Organization details
- Legal name
- Elanco Animal Health Incorporated
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Headquarters city
- Indianapolis
- Headquarters state / province
- Indiana
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ELAN
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0001739104
- EIN
- 82-5497352
Board of directors
-
Art A. Garcia · DirectorSince 2023
-
Craig S. Wallace · DirectorSince 2024
-
Deborah Turner Kochevar · DirectorSince 2023
-
Denise Scots-Knight · DirectorSince 2023
-
Jeffrey N. Simmons · Director · PRESIDENT, CEO AND DIRECTORSince 2023
-
John P. Bilbrey · DirectorSince 2023
-
Kapila K. Anand · DirectorSince 2023
-
Kathy Turner V · DirectorSince 2024
-
Kirk P. McDonald · DirectorSince 2023
-
Lawrence Erik Kurzius · DirectorSince 2023
-
Michael J. Harrington · DirectorSince 2023
-
Paul Herendeen · DirectorSince 2023
-
R. David Hoover · DirectorSince 2023
-
Stacey Ma · DirectorSince 2024
-
William F. Doyle · DirectorSince 2023
Chief executives
Director election results
Annual meeting of May 21, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
79.8%
-
80.4%
-
94.2%
-
94.3%
-
94.7%
Board connections
9 of this board's directors also sit on 16 other boards. 6 are in the same sector.
- via Art A. Garcia
- via Art A. Garcia
-
Charles River Laboratories International Inc. Same sectorvia Deborah Turner Kochevar
- via John P. Bilbrey
-
ImmuCell Corporation Same sectorvia Kathy Turner V
- via Lawrence Erik Kurzius
- via Lawrence Erik Kurzius
-
Mereo BioPharma Group plc Same sectorvia Denise Scots-Knight
-
NovoCure Limited Same sectorvia William F. Doyle
- via Kapila K. Anand
-
ProKidney Corp. Same sectorvia William F. Doyle
- via Art A. Garcia
- via John P. Bilbrey
- via John P. Bilbrey
-
The Cooper Companies Inc. Same sectorvia Lawrence Erik Kurzius
- via Kirk P. McDonald
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $2,610,898
- 11 purchases by 7 insiders
- Sold, last 12 months
- $100,050
- 1 sale by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 15, 2026 | Bettington Timothy J Officer (SEE REMARKS) | Open-market sale | −4,350 | $23.00 | $100,050 |
| Aug 20, 2026 | Lawrence Erik Kurzius Director | Open-market purchase | +40,000 | $23.40 | $936,000 |
| Aug 18, 2026 | O'Neill Shiv Officer (GC AND CORP SEC) | Open-market purchase | +3,998 | $23.58 | $94,273 |
| Aug 12, 2026 | Michael J. Harrington Director | Open-market purchase | +5,000 | $21.82 | $109,100 |
| Aug 7, 2026 | Paul Herendeen Director | Open-market purchase | +10,000 | $23.69 | $236,900 |
| Aug 7, 2026 | VanHimbergen Robert M Officer (EVP and CFO) | Open-market purchase | +4,200 | $23.08 | $96,936 |
| Jul 7, 2026 | VanHimbergen Robert M Officer (EVP and CFO) | Shares withheld for tax | −15,336 | $24.64 | $377,879 |
| May 21, 2026 | Denise Scots-Knight Director | Grant or award | +4,678 | — | — |
| May 21, 2026 | Lawrence Erik Kurzius Director | Grant or award | +4,678 | — | — |
| May 21, 2026 | Kirk P. McDonald Director | Grant or award | +4,678 | — | — |
| May 21, 2026 | Paul Herendeen Director | Grant or award | +4,678 | — | — |
| May 21, 2026 | Deborah Turner Kochevar Director | Grant or award | +4,678 | — | — |
| May 21, 2026 | R. David Hoover Director | Grant or award | +4,678 | — | — |
| May 21, 2026 | Michael J. Harrington Director | Grant or award | +4,678 | — | — |
| May 21, 2026 | Kapila K. Anand Director | Grant or award | +4,678 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Elanco Animal Health Incorporated
Who is the CEO of Elanco Animal Health Incorporated?
Jeffrey N. Simmons is Elanco Animal Health Incorporated's PRESIDENT, CEO AND DIRECTOR.
How many directors are on Elanco Animal Health Incorporated's board?
Elanco Animal Health Incorporated's board has 15 directors: Art A. Garcia, Craig S. Wallace, Deborah Turner Kochevar, Denise Scots-Knight, Jeffrey N. Simmons, John P. Bilbrey, Kapila K. Anand, Kathy Turner V, Kirk P. McDonald, Lawrence Erik Kurzius and 5 others.
Are Elanco Animal Health Incorporated insiders buying or selling shares?
Over the last 12 months, Elanco Animal Health Incorporated insiders bought $2.6 million of shares in 11 purchases and sold $100,050 of shares in 1 sale on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="elanco-animal-health-incorporated"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.